India

In 2014, stem cell research in India, though well established, is considered to be in flux, despite the stem cell therapy market commanding roughly $100 billion a year for several years running. Researchers continue to adapt to new regulations in a complex cultural and political environment. Ethical concerns over the use of human embryonic stem cells are more pressing than in other parts of Asia where the Confucian view that life begins at birth prevails. Stem cell research caught on early in India but did so before there was much of a regulatory framework or guiding oversight in place. By 2007, Indian authors were publishing about 100 peer-reviewed papers a year on stem cell research; by 2010, India was home to almost three dozen research ...